Loading institutional data...
Loading institutional data...
No institutional (13F) filings cover this company, so the Overview and 13F tabs are thin. Everything drawn from its SEC filings is here.
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
6/7 of the 9 checks — 2 couldn't be scored (see above), so the score is out of the 7 with data.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 28% of free cash flow, leaving room to grow it and fund buybacks. Last year: $1.4B dividends + $3.5B buybacks = $5.0B returned on $5.2B FCF.
9 consecutive years of dividend increases · 12%/yr.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Insufficient data. Current ROIC on all capital: 7%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $5.1B covers the $2.7B due within a year 1.9× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.” Effective rate ~52.2% on $31.3B of debt. Interest last disclosed in FY2023 (no longer broken out).
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.08B 100.0% | $18.62B 100.0% | $17.70B 100.0% | $16.53B 100.0% | $15.93B 100.0% | $15.81B 100.0% | $16.46B 100.0% | $16.39B 100.0% | $15.54B 100.0% | — |
| Interest Expense | — | — | $16.30B 92.1% | $3.61B 21.9% | $227.0M 1.4% | $1.13B 7.2% | $4.36B 26.5% | $2.82B 17.2% | $1.07B 6.9% | $437.0M |
| Income Tax Expense | $1.48B 7.3% | $1.30B 7.0% | $979.0M 5.5% | $937.0M 5.7% | $877.0M 5.5% | $842.0M 5.3% | $1.12B 6.8% | $938.0M 5.7% | $496.0M 3.2% | $1.18B |
| Net Income | $5.55B 27.6% | $4.53B 24.3% | $3.30B 18.7% | $2.56B 15.5% | $3.76B 23.6% | $3.62B 22.9% | $4.44B 27.0% | $4.27B 26.0% | $4.09B 26.3% | $3.55B |
| Per Share | ||||||||||
| EPS (Basic) | $7.47 | $5.84 | $3.91 | $2.89 | $4.17 | $3.84 | $4.53 | $4.06 | $3.74 | $3.16 |
| EPS (Diluted) | $7.40 | $5.80 | $3.89 | $2.88 | $4.14 | $3.83 | $4.51 | $4.04 | $3.72 | $3.15 |
| Weighted Avg Shares (Basic) | 710.2M | 742.6M | 784.1M | 811.1M | 851.9M | 890.8M | 939.6M | 1.00B | 1.03B | 1.07B |
| Weighted Avg Shares (Diluted) | 716.7M | 748.1M | 787.8M | 814.8M | 856.4M | 892.5M | 943.1M | 1.01B | 1.04B | 1.07B |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
No current price collected.
No material risks flagged.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Income Tax | 5.7 | 6.8 | 5.3 | 5.5 | 5.7 | 5.5 | 7.0 | 7.3 |
| Net Income | 26.0 | 27.0 | 22.9 | 23.6 | 15.5 | 18.7 | 24.3 | 27.6 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on BNY-PK: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.